Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
493M
-
Number of holders
-
339
-
Total 13F shares, excl. options
-
467M
-
Shares change
-
-8.64M
-
Total reported value, excl. options
-
$4.7B
-
Value change
-
-$72.1M
-
Put/Call ratio
-
0.59
-
Number of buys
-
180
-
Number of sells
-
-195
-
Price
-
$10.06
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q2 2023
462 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q2 2023.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 339 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 467M shares
of 493M outstanding shares and own 94.79% of the company stock.
Largest 10 shareholders include Dodge & Cox (84.6M shares), PRIMECAP MANAGEMENT CO/CA/ (49M shares), VANGUARD GROUP INC (48.6M shares), BlackRock Inc. (27.2M shares), SHAPIRO CAPITAL MANAGEMENT LLC (20.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (17.4M shares), Black Creek Investment Management Inc. (13.8M shares), CITADEL ADVISORS LLC (13.3M shares), Balyasny Asset Management L.P. (11.2M shares), and STATE STREET CORP (9.71M shares).
This table shows the top 339 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.